Latest Epigenetics Stories
DALLAS, September 29, 2014 /PRNewswire/ -- According to the new market research report "Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase,
Genetic changes that occur in patients with the bowel condition Crohn's disease could hold clues to fighting the illness.
Regardless of their stage or type, cancers appear to share a telltale signature of widespread changes to the so-called epigenome, according to a team of researchers.
A team led by researchers at the University of Exeter Medical School and King’s College London has uncovered some of the strongest evidence yet that epigenetic changes in the brain play a role in Alzheimer’s disease.
Every day trillions of blood cells are being formed in our body: from the oxygen-carrying red blood cells to the many types of white blood cells that fight pathogens and infection.
Everyone feels stressed out at times; however, for some stress evolves into mental and physical illnesses that lead to even worse illnesses and issues.
Scientists at the University of Maryland have developed a new, web-based tool that enables researchers to quickly and easily visualize and compare large amounts of genomic information resulting from high-throughput sequencing experiments.
The tiny addition of a chemical mark atop a gene that is well known for its involvement in clinical depression and posttraumatic stress disorder can affect the way a person's brain responds to threats.
Cancer has long been thought to be primarily a genetic disease, but in recent decades scientists have come to believe that epigenetic changes – which don't change the DNA sequence but how it is 'read' – also play a role in cancer.
Transparency Market Research has added a new report titled "Histone Deacetylase Inhibitors Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" to
- Emitting flashes of light; glittering.